Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma.
作者信息
Guo Averill, Pomenti Sydney, Wattacheril Julia
机构信息
Department of Medicine Columbia University Irving Medical Center.
Division of Digestive and Liver Diseases Center for Liver Disease and Transplantation New York Presbyterian Hospital.
出版信息
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):353-358. doi: 10.1002/cld.1057. eCollection 2021 May.
Abstract
摘要
相似文献
1
Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma.肝细胞癌筛查、诊断和治疗中的健康差异
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):353-358. doi: 10.1002/cld.1057. eCollection 2021 May.
2
Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma.肝细胞癌的风险因素以及种族和民族差异评估。
JGH Open. 2020 Apr 15;4(3):351-359. doi: 10.1002/jgh3.12336. eCollection 2020 Jun.
3
Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.美国肝硬化患者的肝癌筛查与早期肿瘤检测和生存改善相关。
Am J Med. 2017 Sep;130(9):1099-1106.e1. doi: 10.1016/j.amjmed.2017.01.021. Epub 2017 Feb 14.
4
[Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017].[法国肝细胞癌患者的护理路径：2017年现状]
Bull Cancer. 2017 Sep;104(9):752-761. doi: 10.1016/j.bulcan.2017.06.008. Epub 2017 Jul 24.
5
Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.在肝癌诊断、治疗及长期生存方面，特定出生队列存在的差异。
J Hepatol. 2016 Feb;64(2):326-332. doi: 10.1016/j.jhep.2015.09.006. Epub 2015 Sep 18.
6
Disparities in the treatment of hepatocellular carcinoma based on geographical region are decreasing.基于地理位置的肝细胞癌治疗差异正在缩小。
J Gastroenterol Hepatol. 2019 Mar;34(3):575-579. doi: 10.1111/jgh.14515. Epub 2018 Nov 18.
7
Women receive more inpatient resections and ablations for hepatocellular carcinoma than men.女性因肝细胞癌接受住院切除和消融治疗的人数比男性多。
World J Hepatol. 2017 Dec 28;9(36):1346-1351. doi: 10.4254/wjh.v9.i36.1346.
8
Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.乙型肝炎病毒相关肝癌风险人群和接受抗病毒治疗人群的肝癌筛查应用。
J Clin Nurs. 2018 Jul;27(13-14):2673-2683. doi: 10.1111/jocn.14367. Epub 2018 May 28.
9
Screening for hepatocellular carcinoma.肝细胞癌筛查
Dig Liver Dis. 2005 Apr;37(4):260-8. doi: 10.1016/j.dld.2004.11.005. Epub 2005 Jan 26.
10
Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation.肝硬化患者肝细胞癌的螺旋CT筛查：假阳性解读的频率及原因
AJR Am J Roentgenol. 2003 Apr;180(4):1007-14. doi: 10.2214/ajr.180.4.1801007.
引用本文的文献
1
Educational, financial, logistical, emotional, and social needs among patients with hepatocellular carcinoma.肝细胞癌患者的教育、经济、后勤、情感和社会需求。
Hepatol Commun. 2025 Jul 21;9(8). doi: 10.1097/HC9.0000000000000739. eCollection 2025 Aug 1.
2
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma.丙型肝炎相关肝细胞癌肝移植中的种族差异
Ann Surg Oncol. 2025 Jan;32(1):426-437. doi: 10.1245/s10434-024-16317-2. Epub 2024 Oct 16.
3
Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma.肝细胞癌治疗中的种族/民族差异与免疫治疗进展
Cancers (Basel). 2024 Jul 3;16(13):2446. doi: 10.3390/cancers16132446.
4
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020.2001-2020 年美国儿童和成人肝细胞癌的发病率和生存率。
Cancer Epidemiol. 2024 Oct;92:102610. doi: 10.1016/j.canep.2024.102610. Epub 2024 Jul 9.
5
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020.2001 - 2020年美国儿童和成人肝细胞癌的发病率及生存率
medRxiv. 2024 Apr 5:2024.03.25.24304564. doi: 10.1101/2024.03.25.24304564.
6
Review of robotic systems for thoracoabdominal puncture interventional surgery.用于胸腹穿刺介入手术的机器人系统综述。
APL Bioeng. 2024 Apr 1;8(2):021501. doi: 10.1063/5.0180494. eCollection 2024 Jun.
7
Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance.评估在进行肝细胞癌监测的脆弱患者中，对美国 LI-RADS 随访建议的依从性。
Radiol Imaging Cancer. 2024 Jan;6(1):e230118. doi: 10.1148/rycan.230118.
8
Sex and Race Disparities in Hepatocellular Carcinoma Surveillance in Patients With Chronic Hepatitis B During COVID-19: A Single-Center Retrospective Review.COVID-19期间慢性乙型肝炎患者肝细胞癌监测中的性别和种族差异：一项单中心回顾性研究
Gastroenterology Res. 2023 Aug;16(4):203-208. doi: 10.14740/gr1614. Epub 2023 Jul 12.
9
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States.在美国，西班牙裔个体在晚期肝癌的III期临床试验中未得到充分代表。
J Hepatocell Carcinoma. 2023 Jul 27;10:1223-1235. doi: 10.2147/JHC.S412446. eCollection 2023.
10
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.肝癌发病率和治疗效果的种族差异。
Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1821. doi: 10.1002/cnr2.1821. Epub 2023 Jun 21.
本文引用的文献
1
Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.性别因素不容忽视：来自美国一项大型多中心研究的女性肝细胞癌特征。
Am J Gastroenterol. 2020 Sep;115(9):1486-1495. doi: 10.14309/ajg.0000000000000643.
2
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.女性患非酒精性脂肪性肝病的风险较低，但进展为该病的风险高于男性：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2021 Jan;19(1):61-71.e15. doi: 10.1016/j.cgh.2020.04.067. Epub 2020 Apr 30.
3
Disparities in Hepatocellular Carcinoma Surveillance: Dissecting the Roles of Patient, Provider, and Health System Factors.肝细胞癌监测中的差异：剖析患者、提供者和医疗体系因素的作用。
J Clin Gastroenterol. 2020 Mar;54(3):218-226. doi: 10.1097/MCG.0000000000001313.
4
Hepatocellular carcinoma surveillance: An evidence-based approach.肝细胞癌监测：基于证据的方法。
World J Gastroenterol. 2019 Apr 7;25(13):1550-1559. doi: 10.3748/wjg.v25.i13.1550.
5
Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation.肝细胞癌中的性别差异：非酒精性脂肪性肝病/脂肪性肝炎及肝移植方面的差异
Hepatoma Res. 2018;4. doi: 10.20517/2394-5079.2018.87. Epub 2018 Oct 18.
6
Epidemiology and Management of Hepatocellular Carcinoma.原发性肝癌的流行病学和管理。
Gastroenterology. 2019 Jan;156(2):477-491.e1. doi: 10.1053/j.gastro.2018.08.065. Epub 2018 Oct 24.
7
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.种族和民族差异对肝细胞癌的表现和结果的影响。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):551-559.e1. doi: 10.1016/j.cgh.2018.05.039. Epub 2018 May 31.
8
Women receive more inpatient resections and ablations for hepatocellular carcinoma than men.女性因肝细胞癌接受住院切除和消融治疗的人数比男性多。
World J Hepatol. 2017 Dec 28;9(36):1346-1351. doi: 10.4254/wjh.v9.i36.1346.
9
Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma.医院安全网指定对肝细胞癌治疗使用和生存的影响。
Cancer. 2018 Feb 15;124(4):743-751. doi: 10.1002/cncr.31066. Epub 2017 Oct 26.
10
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.美国非酒精性脂肪性肝病患病率、严重程度和结局的种族和民族差异：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2018 Feb;16(2):198-210.e2. doi: 10.1016/j.cgh.2017.09.041. Epub 2017 Sep 29.
Zotero 插件